MGC Pharmaceuticals North American distribution partner submits application to Health Canada for ArtemiC™
Glow LifeTech has exclusive rights to market, sell and distribute ArtemiC™ in Canada, USA, Mexico and all Caribbean countries as a food supplement (nutraceutical, dietary supplement, natural health product). The application included included ArtemiC™ supporting COVID-19 Phase II clinical trial results.
MGC Pharmaceuticals Ltd’s (ASX:MXC) (LON:MXC) (OTCMKTS:MGCLF) Canadian-based development and North American distribution partner Glow LifeTech (CNSX:GLOW) (FRA:9DO) has submitted an application to Health Canada to obtain product licences for ArtemiC™ as a Natural Health Product (NHP).
ArtemiC™ was submitted to Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) on March 11, 2021.
Investegate |MGC Pharmaceuticals Announcements | MGC Pharmaceuticals: Application to Health Canada for ArtemiC Approval
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
MGC Pharmaceuticals Ltd s North American distribution partner submits application to Health Canada for ArtemiC™
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Glow Lifetech Corp : Glow LifeTech Submits Application to Health Canada for Natural Health Product Following Successful COVID-19 Phase II Clinical Trial
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.